Repare Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,073 | $52,404 | $13,047 | $2,159 |
Gross Profit | 585 | 51,903 | 12,541 | 1,110 |
EBITDA | -36,571 | 11,317 | -29,945 | -38,378 |
EBIT | -37,059 | 10,816 | -30,451 | -39,427 |
Net Income | -34,774 | 13,162 | -28,030 | -18,879 |
Net Change In Cash | 1,073 | 52,404 | 13,047 | 2,159 |
Free Cash Flow | -30,514 | 11,932 | -28,554 | -32,870 |
Cash | 79,820 | 103,217 | 111,268 | 107,369 |
Basic Shares | 42,445 | 44,024 | 42,139 | 42,102 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $51,133 | $131,830 | $7,600 | $135 |
Gross Profit | 49,182 | 127,646 | 4,256 | -1,652 |
EBITDA | -112,809 | -20,104 | -108,516 | -53,638 |
EBIT | -114,760 | -24,288 | -111,860 | -55,425 |
Net Income | -93,796 | -29,047 | -106,908 | -53,417 |
Net Change In Cash | 51,133 | 131,830 | 7,600 | 135 |
Cost of Revenue | 8,085 | 231,995 | ||
Free Cash Flow | -129,096 | -280 | -87,486 | -8,321 |
Cash | 111,268 | 159,521 | 334,427 | 326,184 |
Basic Shares | 42,093 | 41,922 | 37,818 | 36,902 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.82 |
2024-03-31 | $0.30 |
2023-12-31 | -$0.67 |
2023-09-30 | -$0.45 |
